[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-341539-105":59,"doc-detail-341539-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","acly-alternative-splicing-correlates-with-cancer-phenotypes","ACLY alternative splicing correlates with cancer phenotypes","","ATP-citrate lyase (ACLY) links carbohydrate and lipid metabolism and supplies nucleocytosolic acetyl-CoA for protein acetylation. ACLY has long and short splice isoforms, with the short isoform lacking exon 14. Exon 14 inclusion (PSI) increases across multiple cancers and associates with worse overall survival in pancancer analyses. The study tests whether isoforms differ functionally and finds no clear differences in enzymatic activity, stability, or rescue of ACLY functions in vitro and in Acly knockout cells. In mice, exon 14 deletion does not alter development, metabolism, or intestinal tumor burden. Instead, epithelial splicing regulatory protein 1 (ESRP1) is highly correlated with ACLY splicing, and both ACLY PSI and ESRP1 expression associate with distinct immune tumor signatures.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/acly-alternative-splicing-correlates-with-cancer-phenotypes/341539/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/acly-alternative-splicing-correlates-with-cancer-phenotypes/341539.png","ImageObject",300,407,{"name":92,"@type":93},"Oliver","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-07","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",13,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What is the main relationship between ACLY splicing and cancer phenotypes reported here?","Question",{"text":113,"@type":114},"Exon 14 inclusion (PSI) of ACLY is increased in several cancers and correlates with poorer overall survival in pancancer analysis. The work also links ACLY splicing patterns to tumor immune signatures.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"Do the ACLY long and short splice isoforms show different biochemical activity or stability?",{"text":118,"@type":114},"No discernible differences are observed in enzymatic activity or stability between the isoforms or ACLY phosphomutants in vitro.",{"name":120,"@type":111,"acceptedAnswer":121},"Does deleting Acly exon 14 change development, metabolism, or intestinal tumor burden in mice?",{"text":122,"@type":114},"Deleting Acly exon 14 in mice does not overtly impact development or metabolic physiology and does not attenuate tumor burden in a genetic intestinal cancer model.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},341539,1790183611,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":19,"preview_urls":147},8796095461610,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","RESEARCH ARTICLE  \nACLY alternative splicing correlates with cancer phenotypes  \nReceived for publication, January 27, 2024, and in revised form, April 23, 2024 Published, Papers in Press, May 28, 2024, [https://doi.org/10.1016/j.jbc.2024.107418](https://doi.org/10.1016/j.jbc.2024.107418)  \nJulianna G. Supplee 1,2, Hayley C. Affronti 1, Richard Duan 1, Rebekah C. Brooks3, Zachary E. Stine3, Phuong T. T. Nguyen 1, Laura V. Pinheiro 1, Michael C. Noji 1, Jack M. Drummond 1, Kevin Huang2, Kollin Schultz2, Chi V. Dang3,4,5, Ronen Marmorstein2, *, and Kathryn E. Wellen 1, *  \nFrom the 1Department of Cancer Biology, and 2Department of Biochemistry and Biophysics, University of Pennsylvania, Philadelphia, Pennsylvania, USA; 3The Wistar Institute, Philadelphia, Pennsylvania, USA; 4Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA; 5The Ludwig Institute for Cancer Research, New York, New York, USA Reviewed by members of the JBC Editorial Board. Edited by Philip A. Cole  \nATP-citrate lyase (ACLY) links carbohydrate and lipid metabolism and provides nucleocytosolic acetyl-CoA for protein acetylation. ACLY has two major splice isoforms: the fulllength canonical “long” isoform and an uncharacterized“short” isoform in which exon 14 is spliced out. Exon 14 encodes 10 amino acids within an intrinsically disordered region and includes at least one dynamically phosphorylated residue. Both isoforms are expressed in healthy tissues to varying degrees. Analysis of human transcriptomic data revealed that the percent spliced in (PSI) of exon 14 is increased in several cancers and correlated with poorer overall survival in a pancancer analysis, though not in individual tumor types. This prompted us to explore potential biochemical and functional differences between ACLY isoforms. Here, we show that there are no discernible differences in enzymatic activity or stability between isoforms or phosphomutants of ACLY in vitro. Similarly, both isoforms and phosphomutants were able to rescue ACLY functions, including fatty acid synthesis and bulk histone acetylation, when re-expressed in Acly knockout cells. Deletion of Acly exon 14 in mice did not overtly impact development or metabolic physiology nor did it attenuate tumor burden in a genetic model of intestinal cancer. Notably, expression of epithelial splicing regulatory protein 1 (ESRP1) is highly correlated with ACLY PSI. We report that ACLY splicing is regulated byESRP1. In turn, both ESRP1 expression and ACLY PSI are correlated with speciﬁc immune signatures in tumors. Despite these intriguing patterns of ACLY splicing in healthy and cancer tissues, functional differences between the isoforms remain elusive.  \nFirst noted by Otto Warburg almost 100 years ago, cancer cells have an altered metabolic phenotype compared to healthy cells (1). To survive and proliferate, tumor cells must synthesize macromolecules and maintain energy and redox balance under conditions that are often nutrient- and oxygen-poor, requiring coordinated reprogramming of cellular metabolism. One mechanism to achieve this favorable reprogramming is alternative splicing of metabolic enzymes. RNA splicing is a  \n* For correspondence: Ronen Marmorstein, [marmor@upenn.edu](marmor@upenn.edu); Kathryn E. Wellen, [wellenk@upenn.edu](wellenk@upenn.edu).  \ntightly controlled process; in cancer, aberrant splicing consistently occurs in ways that promote transformation (2). Speciﬁcally, enzymes which are considered as metabolic“gatekeepers” are often alternatively spliced in cancer, such as glutaminase in glutamine metabolism (3), ketohexokinase in fructose metabolism (4), and pyruvate kinase in glycolysis (5). A particularly relevant example is the PKM2 isoform of pyruvate kinase, which is preferentially expressed in cancer and other proliferating cells (5). Compared to PKM1, the PKM2 isoform has altered biochemical activity, undergoes different post-translational modiﬁcations, and may translocate ","cbCaityHSi66eh46","https://ap.wps.com/l/cbCaityHSi66eh46","pdf",4381972,15,"English","# Background: ACLY splicing and cancer metabolism\n## Metabolic context and splicing rationale\n# Results: Isoform function and cancer associations\n## Transcriptomic correlations and survival links\n## In vitro enzymatic activity and stability\n## Cell rescue of ACLY functions\n## Mouse exon 14 deletion phenotypes\n# Regulation and tumor immune signatures\n## ESRP1 regulation of ACLY splicing\n## Linking ACLY PSI and immune signatures","[{\"question\":\"What is the main relationship between ACLY splicing and cancer phenotypes reported here?\",\"answer\":\"Exon 14 inclusion (PSI) of ACLY is increased in several cancers and correlates with poorer overall survival in pancancer analysis. The work also links ACLY splicing patterns to tumor immune signatures.\"},{\"question\":\"Do the ACLY long and short splice isoforms show different biochemical activity or stability?\",\"answer\":\"No discernible differences are observed in enzymatic activity or stability between the isoforms or ACLY phosphomutants in vitro.\"},{\"question\":\"Does deleting Acly exon 14 change development, metabolism, or intestinal tumor burden in mice?\",\"answer\":\"Deleting Acly exon 14 in mice does not overtly impact development or metabolic physiology and does not attenuate tumor burden in a genetic intestinal cancer model.\"}]","ACLY alternative splicing correlates with cancer phenotypes | PDF",1790042442,38,[148,152,156,160],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/dc00d2c5ce72927a034f572099ef28f7.webp",983,1296,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9d3ae3521f7eab4275c4d2dd5c1d3876.webp",982,1294,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ef786f6d7b5179bb89ab26376e371fcc.webp",981,1293,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/79c69327b61bba1651a8fac08b0c1ff8.webp",980,1292]